The Dawn of a New Era in Cancer Screening - Dr. Josh Ofman
Listen now
Description
Dr. Josh Ofman, president of GRAIL, discusses pioneering early cancer detection technologies that are transforming cancer care and the importance of yearly screenings.
More Episodes
Dr. Anurag Singh discusses the impact of GLP-1 agonists like Ozempic on weight loss and muscle health, emphasizing the importance of mitochondrial health for maximizing benefits and safety.
Published 05/02/24
Discover a fresh take on cancer theories with Mark Lintern, a citizen scientist whose unique perspective offers new hope in understanding and potentially treating cancer.
Published 04/30/24